VSEE HEALTH INC
VSEENASDAQ🏆 #3889 by market capUS Equity
$404.18▲ $33.63 (+8.32%)
Simulated price1h—
24h▲ 8.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$4M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
46.1%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
0.4x
Cheap
Otter Score
66
Fair
No chart data available for VSEE.
Trading Snapshot
- Day Range
- $397.98 – $407.37
- 52-Week Range
- $0.01 – $2.52
- Volume
- $3.22B
- Avg Volume
- $3.93B
- Shares Outstanding
- 55.7M
- Next Earnings
- Sep 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $10M
- Last Q Revenue
- $2M
- P/E Ratio
- —
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-0.48
- Dividend Yield
- —
Why Investors Own VSEE
- ✓High-growth profile — revenue up +2.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 59% gross margin and 16% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$10M▼ −1.0% YoY
Gross Margin (TTM)
58.7%▲ +4.2% YoY
Operating Income (TTM)
$3M▼ −1.0% YoY
Free Cash Flow (TTM)
$2M▼ −1.0% YoY
About VSEE HEALTH INC
A company profile for VSEE HEALTH INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
66/100
Analyst Price Target
ⓘAverage Target
$408.72
▲ +1.1% Upside
High Target$462.74
Low Target$340.79
Based on 35 analysts
Latest News & Updates
🚀
Reuters·2h ago
VSEE HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift VSEE price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
VSEE HEALTH INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.